Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer

Vanessa N. Harry, Scott I. Semple, Fiona J. Gilbert, David E. Parkin

Research output: Contribution to journalArticle

168 Citations (Scopus)

Abstract

Objective. To investigate diffusion-weighted magnetic resonance imaging (DWI) as an early and reproducible response indicator in women receiving concurrent radiotherapy and chemotherapy (chemoradiation) for advanced cervical cancer.

Methods. Twenty women with advanced cervical cancer were included in a prospective cohort study. DWI was carried out prior to chemoradiation, repeated after 2 weeks of therapy and at the conclusion of therapy using a 1.5 T MRI scanner. The apparent diffusion coefficient (ADC) was calculated from the diffusion data at each assessment. This was correlated with final tumour response as determined by change in tumour size using MRI and conventional clinical response. Twelve women also underwent 2 separate pre-treatment DWI examinations to test for reproducibility of the ADC measurements.

Results. ADC values after 2 weeks of therapy showed a significant correlation with eventual MR response (p=0.048, p=0.448, Spearman's correlation) and clinical response (p=0.009, p=0.568) as did the change in ADC after 2 weeks of therapy (p=0.01, p=0.56 for MR response, p=0.03, p=0.48 for clinical response). Reproducibility of ADC measurements was confirmed with a mean difference in ADC of -0.003 between consecutive pre-therapy MRI assessments and 95% confidence intervals of -0. 12 and 0.11.

Conclusion. DWI has potential to provide a surrogate biomarker of treatment response in advanced cervical cancers. The use of ADC offers an early and reproducible indication of tumour response which may ultimately allow the development of individualised regimens. (C) 2008 Elsevier Inc. All rights reserved.

Original languageEnglish
Pages (from-to)213-220
Number of pages8
JournalGynecologic Oncology
Volume111
Issue number2
Early online date6 Sep 2008
DOIs
Publication statusPublished - Nov 2008

Keywords

  • diffusion-weighted MRI
  • apparent diffusion coefficient
  • cervical cancer
  • radiotherapy
  • metastatic breast-cancer
  • primary rectal-carcinoma
  • brain-tumors
  • in-vivo
  • radiation-therapy
  • MRI
  • chemotherapy
  • biomarker
  • coefficient
  • progression

Cite this

Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. / Harry, Vanessa N.; Semple, Scott I.; Gilbert, Fiona J.; Parkin, David E.

In: Gynecologic Oncology, Vol. 111, No. 2, 11.2008, p. 213-220.

Research output: Contribution to journalArticle

Harry, Vanessa N. ; Semple, Scott I. ; Gilbert, Fiona J. ; Parkin, David E. / Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. In: Gynecologic Oncology. 2008 ; Vol. 111, No. 2. pp. 213-220.
@article{bd586482bc2e42d0b89166452c4ea508,
title = "Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer",
abstract = "Objective. To investigate diffusion-weighted magnetic resonance imaging (DWI) as an early and reproducible response indicator in women receiving concurrent radiotherapy and chemotherapy (chemoradiation) for advanced cervical cancer.Methods. Twenty women with advanced cervical cancer were included in a prospective cohort study. DWI was carried out prior to chemoradiation, repeated after 2 weeks of therapy and at the conclusion of therapy using a 1.5 T MRI scanner. The apparent diffusion coefficient (ADC) was calculated from the diffusion data at each assessment. This was correlated with final tumour response as determined by change in tumour size using MRI and conventional clinical response. Twelve women also underwent 2 separate pre-treatment DWI examinations to test for reproducibility of the ADC measurements.Results. ADC values after 2 weeks of therapy showed a significant correlation with eventual MR response (p=0.048, p=0.448, Spearman's correlation) and clinical response (p=0.009, p=0.568) as did the change in ADC after 2 weeks of therapy (p=0.01, p=0.56 for MR response, p=0.03, p=0.48 for clinical response). Reproducibility of ADC measurements was confirmed with a mean difference in ADC of -0.003 between consecutive pre-therapy MRI assessments and 95{\%} confidence intervals of -0. 12 and 0.11.Conclusion. DWI has potential to provide a surrogate biomarker of treatment response in advanced cervical cancers. The use of ADC offers an early and reproducible indication of tumour response which may ultimately allow the development of individualised regimens. (C) 2008 Elsevier Inc. All rights reserved.",
keywords = "diffusion-weighted MRI, apparent diffusion coefficient, cervical cancer, radiotherapy, metastatic breast-cancer, primary rectal-carcinoma, brain-tumors, in-vivo, radiation-therapy, MRI, chemotherapy, biomarker, coefficient, progression",
author = "Harry, {Vanessa N.} and Semple, {Scott I.} and Gilbert, {Fiona J.} and Parkin, {David E.}",
year = "2008",
month = "11",
doi = "10.1016/j.ygyno.2008.07.048",
language = "English",
volume = "111",
pages = "213--220",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer

AU - Harry, Vanessa N.

AU - Semple, Scott I.

AU - Gilbert, Fiona J.

AU - Parkin, David E.

PY - 2008/11

Y1 - 2008/11

N2 - Objective. To investigate diffusion-weighted magnetic resonance imaging (DWI) as an early and reproducible response indicator in women receiving concurrent radiotherapy and chemotherapy (chemoradiation) for advanced cervical cancer.Methods. Twenty women with advanced cervical cancer were included in a prospective cohort study. DWI was carried out prior to chemoradiation, repeated after 2 weeks of therapy and at the conclusion of therapy using a 1.5 T MRI scanner. The apparent diffusion coefficient (ADC) was calculated from the diffusion data at each assessment. This was correlated with final tumour response as determined by change in tumour size using MRI and conventional clinical response. Twelve women also underwent 2 separate pre-treatment DWI examinations to test for reproducibility of the ADC measurements.Results. ADC values after 2 weeks of therapy showed a significant correlation with eventual MR response (p=0.048, p=0.448, Spearman's correlation) and clinical response (p=0.009, p=0.568) as did the change in ADC after 2 weeks of therapy (p=0.01, p=0.56 for MR response, p=0.03, p=0.48 for clinical response). Reproducibility of ADC measurements was confirmed with a mean difference in ADC of -0.003 between consecutive pre-therapy MRI assessments and 95% confidence intervals of -0. 12 and 0.11.Conclusion. DWI has potential to provide a surrogate biomarker of treatment response in advanced cervical cancers. The use of ADC offers an early and reproducible indication of tumour response which may ultimately allow the development of individualised regimens. (C) 2008 Elsevier Inc. All rights reserved.

AB - Objective. To investigate diffusion-weighted magnetic resonance imaging (DWI) as an early and reproducible response indicator in women receiving concurrent radiotherapy and chemotherapy (chemoradiation) for advanced cervical cancer.Methods. Twenty women with advanced cervical cancer were included in a prospective cohort study. DWI was carried out prior to chemoradiation, repeated after 2 weeks of therapy and at the conclusion of therapy using a 1.5 T MRI scanner. The apparent diffusion coefficient (ADC) was calculated from the diffusion data at each assessment. This was correlated with final tumour response as determined by change in tumour size using MRI and conventional clinical response. Twelve women also underwent 2 separate pre-treatment DWI examinations to test for reproducibility of the ADC measurements.Results. ADC values after 2 weeks of therapy showed a significant correlation with eventual MR response (p=0.048, p=0.448, Spearman's correlation) and clinical response (p=0.009, p=0.568) as did the change in ADC after 2 weeks of therapy (p=0.01, p=0.56 for MR response, p=0.03, p=0.48 for clinical response). Reproducibility of ADC measurements was confirmed with a mean difference in ADC of -0.003 between consecutive pre-therapy MRI assessments and 95% confidence intervals of -0. 12 and 0.11.Conclusion. DWI has potential to provide a surrogate biomarker of treatment response in advanced cervical cancers. The use of ADC offers an early and reproducible indication of tumour response which may ultimately allow the development of individualised regimens. (C) 2008 Elsevier Inc. All rights reserved.

KW - diffusion-weighted MRI

KW - apparent diffusion coefficient

KW - cervical cancer

KW - radiotherapy

KW - metastatic breast-cancer

KW - primary rectal-carcinoma

KW - brain-tumors

KW - in-vivo

KW - radiation-therapy

KW - MRI

KW - chemotherapy

KW - biomarker

KW - coefficient

KW - progression

U2 - 10.1016/j.ygyno.2008.07.048

DO - 10.1016/j.ygyno.2008.07.048

M3 - Article

VL - 111

SP - 213

EP - 220

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -